The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
95 jobs Number of planned job losses
Announcement Date
19 April 2023
Employment effect (start)
1 May 2023
Foreseen end date
Description
The Swedish pharmaceutical group Recipharm has announced the loss of 95 jobs at its site in Monts (Indre-et-Loire). This site is specialised in Blow Fill Seal (BFS) technology, which allows the vial to be formed, filled and sealed by the same machine under perfectly aseptic conditions. As a result of the lack of orders for Moderna vaccines against Covid-19, the site has had to reduce its production, which has had an impact on the workforce. In the midst of the Covid-19 crisis, the company received a visit from the Minister of Industry, Agnès Pannier-Runacher, who promised €35 million in support as part of the France Recovery Plan. The site subsequently hired a hundred people in 2021 before announcing 100 recruitments in 2022 (FR-Recipharm-2022).
By December 2022, the pharmaceutical company had switched to a four-day week, with a reduction in salary. But the measure is insufficient and management has announced a voluntary redundancy plan signed with the site's representative union for the implementation of a collective termination of employment contracts (Rupture conventionnelle collective) for 95 positions, out of a total of 320 positions, or nearly one third of the workforce.
The management intends to carry out this reorganisation 'in an exemplary manner'. An employment unit will be set up to assist employees who wish to leave. In addition to compensation, the group has released €10,000 for training for each employee.
Eurofound (2023), Recipharm Monts, Internal restructuring in France, factsheet number 108841, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/108841.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...